Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
Düzenleme ve hukuk · 08.12.20171 dk okuma
Prospective Grant of Exclusive Patent License: N-Acetyl Mannosamine as a Therapeutic Agent
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The National Human Genome Research Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Leadiant Biosciences, Inc, located in Gaithersburg, Maryland, USA.
Kaynağın orijinal dili: Federal Register — All DocumentsOrijinal duyuruyu açın →